Leadership Team

Yael Karlin, CEO

Ms. Yael Karlin has extensive international experience in the start-up ecosystem with a comprehensive knowledge of the life science industry. Since 2008, she has advised and coached start-ups on strategy, business development, and raising capital.
Ms. Karlin excels at creating partnerships, generating R&D and licensing agreements, commercialisation, joint ventures, and acquisitions.

She has held sales and marketing positions at Cordis, and at Johnson & Johnson – both in Israel and in Belgium, and led the marketing activity for a US-based start-up. Prior to that, she directed the Start-up Center at the Israeli Export Institute, and filled a technology matchmaking position at Ernst & Young Israel.

Yael holds an MBA and a BA in Management from Ben Gurion University, Israel, and is fluent in English, French and Hebrew.

Dr. Amir Kraitzer, Founder and CTO

Dr. Amir Kraitzer is a biomaterials specialist, entrepreneur, and inventor in the field of medical devices. He has a proven track record in management and problem-solving in both industrial and scientific environments.

Dr. Kraitzer has acquired vast expertise in engineering polymeric materials for medical use, bio-resorbable polymers and cements, biomaterials, controlled drug release and tissue engineering. He also has broad experience in medical device technology, product development, manufacturing and commercialization, and compliance with regulatory requirements – both in the U.S. and the Europe.
Previously, he was a co-founder and CEO of Augma – a biomaterials company which developed biodegradable cement-based bone graft substitutes.

Amir holds a PhD, Bio-Medical Engineering; MBA, Strategy and entrepreneurship; MSc, Materials Science and Engineering – Biomaterials and implantable medical devices, graduated cum laude, and BSc, Mechanical Engineering Energy, Control and Robotics – all from the Tel-Aviv University, Israel.